Literature DB >> 15329070

Univerricht-Lundborg disease: underdiagnosed in the Netherlands.

Gerrit-Jan de Haan1, Dicky J J Halley, Jan C Doelman, Huibert H Geesink, Paul B Augustijn, Anke D Jager-Jongkind, Marianne Majoie, Adri J Bader, Lian A W M Leliefeld-Ten Doeschate, Wout H Deelen, Ed Bertram, Anna E Lehesjoki, Dick Lindhout.   

Abstract

PURPOSE: Univerricht-Lundborg disease (ULD), with its major symptom of action myoclonus, is supposed to be very rare in the Netherlands and western Europe. We hypothesized that the syndrome may be underdiagnosed in patients with myoclonus epilepsy.
METHODS: Mutation analysis of the cystatin B gene was performed in 21 cases with uncontrolled myoclonus.
RESULTS: Seven of the 21 evaluated cases carried mutations in the cystatin B gene. Diagnosis of ULD was made with a mean delay of 20 years from symptom onset.
CONCLUSIONS: This study from a country without previous reports of ULD suggests that underdiagnosis of the syndrome is likely. These findings also indicate that persons with juvenile-onset myoclonus epilepsy with action myoclonus should be analyzed for ULD. Copyright 2004 International League Against Epilepsy

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15329070     DOI: 10.1111/j.0013-9580.2004.43703.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

1.  Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.

Authors:  Mira Polajnar; Slavko Ceru; Nataša Kopitar-Jerala; Eva Zerovnik
Journal:  Front Mol Neurosci       Date:  2012-08-24       Impact factor: 5.639

2.  Progressive myoclonic epilepsy type 1: Report of an Emirati family and literature review.

Authors:  Mohammed Saadah; Mahfoud El Beshari; Loai Saadah; Hisham Hamdallah; Zeinab Alloub; Amani Ali Al Zaabi; Abdelmatlob Ben-Mussa; Anwaar Ben-Nour
Journal:  Epilepsy Behav Case Rep       Date:  2014-05-04

3.  First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.

Authors:  Ki Hoon Kim; Ju Sun Song; Chan Wook Park; Chang Seok Ki; Kyoung Heo
Journal:  Yonsei Med J       Date:  2018-08       Impact factor: 2.759

4.  Characterization of a rare Unverricht-Lundborg disease mutation.

Authors:  Ana Joana Duarte; Diogo Ribeiro; João Chaves; Olga Amaral
Journal:  Mol Genet Metab Rep       Date:  2015-08-05

5.  Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.

Authors:  R Stevelink; B P C Koeleman; J W Sander; F E Jansen; K P J Braun
Journal:  Eur J Neurol       Date:  2018-10-07       Impact factor: 6.089

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.